Clinical Presentation of Ovarian Tumors

Muhabat, Qamarunissa; Waheed, Fakharunissa; Waqarunissa,; Jabeen, Nigar

doi:10.4236/ojog.2016.64026

Cited by 7 publications

(6 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Muhabat Q studied 43% patients were presented with ovarian tumour after >1 year of symptoms. 15 In present study, benign neoplasma were 79.2%, borderline 1.5% and malignant neoplasia were 19.2%. Similarly, in study conducted by Yogambal M et al, they studied out of 402 patients with ovarian mass, benign neoplasma were 78.6%, borderline 0.75% and malignant neoplasia were 20.65%.…”

Section: Discussionsupporting

confidence: 45%

See 1 more Smart Citation

Prevalence of ovarian tumours among ovarian mass lesions in Gajra Raja Medical College, Gwalior, India

Bindal

Bankey

2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Ovarian tumor is one of the most common gynecological tumors seen in female although there are different types of ovarian tumor but epithelial ovarian cancer is the fifth most common cause of cancer death in women. It is often called the "silent killer" because the disease is not often detected until it reaches an advance stage. Methods: This observational study conducted on 130 patients from February 2015 to March 2017 in the Department of Obstetrics and Gynaecology in Gajra Raja Medical College, Gwalior. Clinical details of the patients included age, gynaecological and obstetric history, presenting symptoms, and surgery details. Histopathological reporting was done at our Pathology department. Results: Out of total 130 patients with ovarian tumours studied 49.2% were > 60 years of age group, most of them were nullipara (53.8%), 54.6% with ovarian tumours presented after one-year development of symptoms. most of the symptoms were vague and nonspecific. Benign tumours were the most prevalent (79.2%), 19.2% were malignant tumours and 1.5% were borderline. Histological pattern of distribution of ovarian tumour shows that most of ovarian tumour were surface epithelial tumour (72 patients) followed by germ cell tumour (58 patients). Age wise distribution of study population showed that most of the surface epithelial tumour were more common in 3 rd to 5 th decade while most of germ cell tumour were more frequent in 2 nd and 3 rd decade. Conclusions: For better prognosis and patient survival, early detection and treatment is mandatory, which may reduce mortality. There is need to increase awareness of population. Abdominal and pelvic bimanual examination should be carried out in every patient presenting with gynecological problem. Appropriate investigations in post-menopausal women in early period to diagnose the disease at an early stage.

show abstract

Section: Discussionsupporting

confidence: 45%

“…15 In present study, 53.8% women who had ovarian tumor were nullipara while 20.8% multipara. However, in study conducted by Khan I, at KEMU/Lady Willington hospital, 58.15% women who had ovarian tumor were multipara.…”

Section: Discussionmentioning

confidence: 44%

Prevalence of ovarian tumours among ovarian mass lesions in Gajra Raja Medical College, Gwalior, India

Bindal

Bankey

2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…The main documented comorbidities were overweight (45.2%) and systemic arterial hypertension (43%). The main symptoms were abdominal and nonspecific, in accordance with the literature [43], highlighting the increase in abdominal girth in 40 patients (75.5%) and diffuse abdominal pain in 35 (66.6%).…”

Section: Discussionsupporting

confidence: 88%

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

et al. 2021

View full text Add to dashboard Cite

Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than 65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant chemotherapy (NACT). Methods A prospective-longitudinal study was conducted among women with advanced epithelial ovarian cancer (AEOC), III and IV stages, and treated with NACT, at the National Cancer Institute – Mexico, from July 2017 to July 2018. Serum samples were obtained for quantification of CA125 and HE4 using ELISA at the first and in each of the three NACT cycles. The therapeutic response was evaluated through standard tomography. We determined whether CA125 and HE4, alone or in combination, were associated with TR to NACT during follow up. Results 53 patients aged 38 to 79 years were included, 92.4% presented papillary serous subtype OC. Higher serum HE4 levels were observed in patients with non-tomographic response (6.89 vs 5.19 pmol/mL; p = 0.031), specially during the second (p = 0.039) and third cycle of NACT (p = 0.031). Multivariate-adjusted models showed an association between HE4 levels and TR, from the second treatment cycle (p = 0.042) to the third cycle (p = 0.033). Changes from baseline HE4 levels during the first cycle was negative associated with TR. No associations were found between CA125 and TR. Conclusions Serum HE4 levels were independently associated with TR among patients with AOEC treated with NACT, also a reduction between baseline HE4 and first chemotherapy levels was also independently associated with the TR. These findings might be relevant for predicting a lack of response to treatment.

show abstract

“…Many of our patients also presented with abnormal menstrual history. Hence an Abdominal and pelvic examination is mandatory in every patient presenting with abdominal pain in the gynecological OPD and appropriate investigations must be carried out to diagnose the ovarian lesion at an early stage [9] . In our study we had a higher incidence of 39/69 benign cases followed by 24/69 non neoplastic cases and 6/69 malignant cases.…”

Section: Discussionmentioning

confidence: 99%

Histopathological patterns of ovarian lesions in various age groups-3 year study in a rural population

Gandhi¹,

Sriram²,

Jayanthi³

et al. 2020

Int. J. Clin. Diagn. Pathol.

View full text Add to dashboard Cite

Introduction: Ovarian lesions are commonly encountered and are complex in gynecological practice which can be either benign, borderline or malignant which constitutes a high fatality rate and it cannot be categorized clinico -radiologically. Definite diagnosis is of great importance for therapeutic and prognostic purposes. Histopathology gives accurate diagnosis in most of the cases. Aims: To study the histopathological pattern of ovarian lesions in different age group and also to analyse the associated clinical and radiological findings. Methods: A retrospective study conducted on 69 cases of ovarian lesions reported from June 2016-May 2019 in pathology department at Sri Manakula Vinayagar medical college and hospital, Puducherry Results: Out of sixty nine ovarian lesions, 24 were non neoplastic and 45 were neoplastic lesions. Out of the neoplastic lesions 39 were benign and 6 were malignant. Among non-neoplastic lesions follicular cyst 12 was the most common lesion followed by endometriotic cysts 10. The majority of the cases were seen in the age group of 41-50 years. Conclusion: Most ovarian lesions were common in the age group 20-50 years. Neoplastic ovarian lesions are more common than non-neoplastic lesion.

show abstract

Clinical Presentation of Ovarian Tumors

Cited by 7 publications

References 29 publications

Prevalence of ovarian tumours among ovarian mass lesions in Gajra Raja Medical College, Gwalior, India

Prevalence of ovarian tumours among ovarian mass lesions in Gajra Raja Medical College, Gwalior, India

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Histopathological patterns of ovarian lesions in various age groups-3 year study in a rural population

Contact Info

Product

Resources

About